Time: 4:00 pm - 5:00 pm
Supported by Astellas Pharma US, Inc.
Title: A Deeper Dive into the Use of Myrbetriq® (mirabegron) in Patients 65 and Older with OAB Symptoms of Urge Urinary Incontinence, Urgency, and Urinary Frequency
Description: In this session, we will discuss the clinical impact and physiology of overactive bladder as well as the latest perspectives on management and treatment.
Faculty: Jo Ann Fisher, MSN, FNP-BC